Vicky Steadman BSc, PhD

Vicky brings to Selcia significant big pharma experience having previously worked in senior scientific roles at GlaxoSmithKline (2005 – 2008) and Merck Sharp and Dohme (2002 – 2005). This was preceded by a two year placement in the USA as a Royal Society Fulbright Postdoctoral Fellow.
Her main areas of therapeutic interest and experience include anti-viral macrolides (Hepatitis C), anti-bacterials (MRSA), anti-inflammatory macrocyclic natural products, and kinase inhibitors and gamma-secretase modulators (both for Alzheimer’s disease). She is named on over 20 peer reviewed papers and patents.
Vicky has a BSc in chemistry from Imperial College and a PhD in organic chemistry from the University of Cambridge. She is a Fellow of the Royal Society of Chemistry and has served on the SCI’s Fine Chemicals Group Committee.